PEN

SEC source: 0002086163-26-000010 · wk-form4_1789687914.xml · nonDerivative · entry 1

Narayan Shruthi · CIK 0002086163 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,650

F1 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0002086163-26-000008 · wk-form4_1787181795.xml · nonDerivative · entry 1

Narayan Shruthi · CIK 0002086163 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,880

F1 · shares: On August 17, 2026, the Reporting Person was granted 3,060 restricted stock units ("RSUs") under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs (each, an "Equity Grant Tranche") will vest equally on an annual basis, beginning on August 15, 2027, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation and Pinehurst Merger Sub, Inc.) occurs, the RSUs will vest as follows: the first two Equity Grant Tranches (to the extent not already vested) shall vest on the Closing, and the last two Equity Grant Tranches (to the extent not already vested) shall vest on the first and second anniversaries of the Closing, respectively, subject to continued service by the Reporting Person on the applicable vesting date.

F2 · balance_after: A portion of these shares is subject to vesting.

F3 · balance_after: Includes 65 shares purchased by the Reporting Person under the Issuer's Employee Stock Purchase Plan on May 19, 2026.

SEC source: 0001651323-26-000002 · wk-form4_1779406545.xml · nonDerivative · entry 1

Elsesser Adam · CIK 0001651323 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 683,042

F1 · kind: Charitable donation to Massachusetts school focused on educating students with complex language and learning challenges.

F2 · balance_after: Any changes between direct and indirect holdings through the Siegel/Elsesser Revocable Trust are in transactions exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934 as mere changes in form of beneficial ownership.

F3 · ownership.nature: Shares are held by the Siegel/Elsesser Revocable Trust.

SEC source: 0001375889-26-000006 · wk-form4_1775520139.xml · nonDerivative · entry 1

Grewal Harpreet · CIK 0001375889 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,719

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0002086163-26-000006 · wk-form4_1773790417.xml · nonDerivative · entry 1

Narayan Shruthi · CIK 0002086163 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,755

F1 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001796068-26-000004 · wk-form4_1773790301.xml · nonDerivative · entry 1

Shiu Lambert · CIK 0001796068 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,323

F1 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001751980-26-000004 · wk-form4_1773790361.xml · nonDerivative · entry 1

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,298

F1 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001796057-26-000006 · wk-form4_1773790331.xml · nonDerivative · entry 1

Yuen Maggie · CIK 0001796057 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,167

F1 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001796057-26-000004 · wk-form4_1772670697.xml · nonDerivative · entry 1

Yuen Maggie · CIK 0001796057 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,353

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0002086163-26-000004 · wk-form4_1771462942.xml · nonDerivative · entry 3

Narayan Shruthi · CIK 0002086163 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,872

F4 · shares: On February 17, 2026, the Reporting Person was granted 2,630 RSUs under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on an annual basis, beginning on February 15, 2027, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001796068-26-000002 · wk-form4_1771462951.xml · nonDerivative · entry 3

Shiu Lambert · CIK 0001796068 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,473

F4 · shares: On February 17, 2026, the Reporting Person was granted 2,300 RSUs under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on an annual basis, beginning on February 15, 2027, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001751980-26-000002 · wk-form4_1771463008.xml · nonDerivative · entry 3

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,484

F4 · shares: On February 17, 2026, the Reporting Person was granted 2,630 RSUs under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on an annual basis, beginning on February 15, 2027, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001796057-26-000002 · wk-form4_1771462991.xml · nonDerivative · entry 3

Yuen Maggie · CIK 0001796057 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,785

F4 · shares: On February 17, 2026, the Reporting Person was granted 2,630 RSUs under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on an annual basis, beginning on February 15, 2027, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0002086163-26-000004 · wk-form4_1771462942.xml · nonDerivative · entry 2

Narayan Shruthi · CIK 0002086163 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,242

F3 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs granted to the Reporting Person.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001796068-26-000002 · wk-form4_1771462951.xml · nonDerivative · entry 2

Shiu Lambert · CIK 0001796068 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,173

F3 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs granted to the Reporting Person.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001751980-26-000002 · wk-form4_1771463008.xml · nonDerivative · entry 2

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,854

F3 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs granted to the Reporting Person.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001796057-26-000002 · wk-form4_1771462991.xml · nonDerivative · entry 2

Yuen Maggie · CIK 0001796057 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,155

F3 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs granted to the Reporting Person.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0002086163-26-000004 · wk-form4_1771462942.xml · nonDerivative · entry 1

Narayan Shruthi · CIK 0002086163 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,947

F1 · shares: On February 13, 2026, the Reporting Person was granted 2,630 restricted stock units (RSUs) under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on February 15, 2026, February 15, 2027, February 15, 2028 and February 15, 2029, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001796068-26-000002 · wk-form4_1771462951.xml · nonDerivative · entry 1

Shiu Lambert · CIK 0001796068 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,585

F1 · shares: On February 13, 2026, the Reporting Person was granted 2,300 restricted stock units (RSUs) under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on February 15, 2026, February 15, 2027, February 15, 2028 and February 15, 2029, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001781561-26-000002 · wk-form4_1771463043.xml · nonDerivative · entry 1

Sarna Surbhi · CIK 0001781561 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,293

F1 · shares: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Ms. Sarna's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Ms. Sarna's continued service as director through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001751980-26-000002 · wk-form4_1771463008.xml · nonDerivative · entry 1

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,336

F1 · shares: On February 13, 2026, the Reporting Person was granted 2,630 restricted stock units (RSUs) under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on February 15, 2026, February 15, 2027, February 15, 2028 and February 15, 2029, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001491299-26-000004 · wk-form4_1771463016.xml · nonDerivative · entry 1

Wilder Thomas · CIK 0001491299 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 589

F1 · shares: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Mr. Wilder's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Mr. Wilder's continued service as director through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001375889-26-000004 · wk-form4_1771463100.xml · nonDerivative · entry 1

Grewal Harpreet · CIK 0001375889 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,819

F1 · shares: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Mr. Grewal's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Mr. Grewal's continued service as director through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001651318-26-000002 · wk-form4_1771463094.xml · nonDerivative · entry 1

Bose Arani · CIK 0001651318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,147

F1 · shares: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Dr. Bose's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Dr. Bose's continued service as director through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001765394-26-000002 · wk-form4_1771463069.xml · nonDerivative · entry 1

Leeds Janet · CIK 0001765394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,639

F1 · shares: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Ms. Leeds' continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Ms. Leeds' continued service as director through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001704713-26-000002 · wk-form4_1771463049.xml · nonDerivative · entry 1

O'Rourke Bridget · CIK 0001704713 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,962

F1 · shares: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Ms. O'Rourke's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Ms. O'Rourke's continued service as director through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001796057-26-000002 · wk-form4_1771462991.xml · nonDerivative · entry 1

Yuen Maggie · CIK 0001796057 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,636

F1 · shares: On February 13, 2026, the Reporting Person was granted 2,630 restricted stock units (RSUs) under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on February 15, 2026, February 15, 2027, February 15, 2028 and February 15, 2029, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0002086163-26-000002 · wk-form4_1768611003.xml · nonDerivative · entry 1

Narayan Shruthi · CIK 0002086163 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,317

F1 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person.

SEC source: 0001375889-26-000002 · wk-form4_1767924378.xml · nonDerivative · entry 1

Grewal Harpreet · CIK 0001375889 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,230

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

SEC source: 0001491299-26-000002 · wk-form4_1767746013.xml · nonDerivative · entry 1

Wilder Thomas · CIK 0001491299 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

SEC source: 0001796068-25-000005 · wk-form4_1766019594.xml · nonDerivative · entry 1

Shiu Lambert · CIK 0001796068 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,285

F1 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person.

F2 · balance_after: A portion of these shares is subject to vesting.

F3 · balance_after: Includes 20 shares purchased by the Reporting Person under the Issuer's Employee Stock Purchase Plan on November 19, 2025.

SEC source: 0001751980-25-000033 · wk-form4_1766019574.xml · nonDerivative · entry 1

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,706

F1 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001796057-25-000009 · wk-form4_1766019615.xml · nonDerivative · entry 1

Yuen Maggie · CIK 0001796057 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,006

F1 · kind: Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person.

F2 · balance_after: A portion of these shares is subject to vesting.

F3 · balance_after: Includes 15 shares purchased by the Reporting Person under the Issuer's Employee Stock Purchase Plan on November 19, 2025.

SEC source: 0001651318-25-000009 · wk-form4_1765845008.xml · nonDerivative · entry 7

Bose Arani · CIK 0001651318 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By LLC

Disclosed balance after: 258,462

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F8 · price: This transaction was executed in multiple trades at prices ranging from $312.00 to $312.62. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Shares are held by Bose Family Holdings II, LLC.

SEC source: 0001651318-25-000009 · wk-form4_1765845008.xml · nonDerivative · entry 6

Bose Arani · CIK 0001651318 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By LLC

Disclosed balance after: 260,357

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $311.00 to $311.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Shares are held by Bose Family Holdings II, LLC.

SEC source: 0001651318-25-000009 · wk-form4_1765845008.xml · nonDerivative · entry 5

Bose Arani · CIK 0001651318 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By LLC

Disclosed balance after: 263,880

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $310.00 to $310.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Shares are held by Bose Family Holdings II, LLC.

SEC source: 0001651318-25-000009 · wk-form4_1765845008.xml · nonDerivative · entry 4

Bose Arani · CIK 0001651318 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By LLC

Disclosed balance after: 265,962

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F3 · ownership.nature: Shares are held by Bose Family Holdings II, LLC.

SEC source: 0001651318-25-000009 · wk-form4_1765845008.xml · nonDerivative · entry 3

Bose Arani · CIK 0001651318 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By LLC

Disclosed balance after: 265,966

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $307.00 to $307.67. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Shares are held by Bose Family Holdings II, LLC.

SEC source: 0001651318-25-000009 · wk-form4_1765845008.xml · nonDerivative · entry 2

Bose Arani · CIK 0001651318 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By LLC

Disclosed balance after: 266,486

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $306.01 to $306.93. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Shares are held by Bose Family Holdings II, LLC.

SEC source: 0001651318-25-000009 · wk-form4_1765845008.xml · nonDerivative · entry 1

Bose Arani · CIK 0001651318 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By LLC

Disclosed balance after: 271,432

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $305.00 to $305.96. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · ownership.nature: Shares are held by Bose Family Holdings II, LLC.

SEC source: 0001751980-25-000031 · wk-form4_1765328467.xml · nonDerivative · entry 1

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,836

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $300.00 to $300.39. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001375889-25-000009 · wk-form4_1764809065.xml · nonDerivative · entry 1

Grewal Harpreet · CIK 0001375889 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,416

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001751980-25-000029 · wk-form4_1764809102.xml · nonDerivative · entry 7

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,136

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F9 · price: This transaction was executed in multiple trades at prices ranging from $297.89 to $298.14. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001751980-25-000029 · wk-form4_1764809102.xml · nonDerivative · entry 6

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,146

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F8 · price: This transaction was executed in multiple trades at prices ranging from $297.04 to $297.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001751980-25-000029 · wk-form4_1764809102.xml · nonDerivative · entry 5

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,224

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $295.92 to $296.82. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001751980-25-000029 · wk-form4_1764809102.xml · nonDerivative · entry 4

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,304

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $294.95 to $295.84. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001751980-25-000029 · wk-form4_1764809102.xml · nonDerivative · entry 3

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,448

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $294.09 to $294.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001751980-25-000029 · wk-form4_1764809102.xml · nonDerivative · entry 2

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,603

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $292.96 to $293.73. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001751980-25-000029 · wk-form4_1764809102.xml · nonDerivative · entry 1

Roberts Johanna · CIK 0001751980 · EVP, Gen. Counsel & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,642

F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $291.89 to $292.82. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: A portion of these shares is subject to vesting.

SEC source: 0001651318-25-000007 · wk-form4_1764203773.xml · nonDerivative · entry 2

Bose Arani · CIK 0001651318 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By LLC

Disclosed balance after: 273,462

F4 · kind: This was a bona fide gift with no payment in consideration.

F3 · ownership.nature: Shares are held by Bose Family Holdings II, LLC.